pharma · Breast Neoplasms · Radiation Injuries
Sun Yat-sen Memorial
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sun Yat-sen Memorial clinical programs — 7 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Guangzhou, CN
- Employees
- 32
- Programs
- 7
- Drugs
- 16
- Patents
- 0
Sun Yat-sen Memorial projects
7 ClinicalTrials.gov programs sponsored by Sun Yat-sen Memorial.
Sun Yat-sen Memorial has 7 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Carrellizumab + Capecitabine
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Breast Neoplasms
1 trial -
Fulvestrant combined with Pyrotinib
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Breast Cancer
1 trial -
Trastuzumab and neratinib
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Early-stage Breast Cancer
1 trial -
Donepezil Hydrochloride
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Radiation Injuries
1 trial -
Niraparib
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Platinum-resistant Recurrent Clear Cell Ovarian Cancer
1 trial -
Pregabalin
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Neuropathic Pain
1 trial -
Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Breast Cancers
1 trial
Frequently asked questions
How many clinical projects does Sun Yat-sen Memorial have?
7 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.